Randomized trial of a web-based intervention to address barriers to clinical trials

Journal of Clinical Oncology

Volumn 34, Issue 5, 2016, Pages 469-478

  Meropol, Neal J ^a,b   Wong, Yu Ning ^d   Albrecht, Terrance ^h   Manne, Sharon ⁱ   Miller, Suzanne M ^d   Flamm, Anne Lederman ^c   Benson, Al Bowen ^j   Buzaglo, Joanne ^e   Collins, Michael ^d   Egleston, Brian ^d   Fleisher, Linda ^f   Katz, Michael ^k   Kinzy, Tyler G ^b   Liu, Tasnuva M ^b   Margevicius, Seunghee ^b   Miller, Dawn M ^b,d   Poole, David ^g   Roach, Nancy ^l   Ross, Eric ^d   Schluchter, Mark D ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d TEMPLE UNIVERSITY HEALTH SYSTEM   (United States)

^e Cancer Support Community Research and Training Institute   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h WAYNE STATE UNIVERSITY   (United States)

ⁱ RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

^k International Myeloma Foundation   (United States)

^l Patient Advocacy   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; EXPLORATORY RESEARCH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; WEB BROWSER; AGED; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; DECISION MAKING; EARLY CHILDHOOD INTERVENTION; FOLLOW UP; INTERNET; MEDICAL INFORMATION; MULTICENTER STUDY; NATIONAL HEALTH ORGANIZATION; NEOPLASMS; PROCEDURES; PROGNOSIS; QUESTIONNAIRE; UNITED STATES; UTILIZATION;

AGED; CASE-CONTROL STUDIES; CLINICAL TRIALS AS TOPIC; DECISION MAKING; EARLY INTERVENTION (EDUCATION); FEMALE; FOLLOW-UP STUDIES; HEALTH COMMUNICATION; HUMANS; INTERNET; MALE; MIDDLE AGED; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PATIENT EDUCATION AS TOPIC; PROGNOSIS; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84958765343     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.63.2257     Document Type: Article

References (52)

1. Go RS, Frisby KA, Lee JA, et al: Clinical trial accrual among new cancer patients at a communitybased cancer center. Cancer 106:426-433, 2006
2. Murthy VH, Krumholz HM, Gross CP: Participation in cancer clinical trials: race-, sex-, and agebased disparities. JAMA 291:2720-2726, 2004
3. Al-Refaie WB, Vickers SM, Zhong W, et al: Cancer trials versus the real world in the United States. Ann Surg 254:438-442; discussion 442-443, 2011
4. Townsley CA, Selby R, Siu LL: Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 23: 3112-3124, 2005
5. Virani S, Burke L, Remick SC, et al: Barriers to recruitment of rural patients in cancer clinical trials. J Oncol Pract 7:172-177, 2011
6. Eads JR, Albrecht TL, Egleston B, et al: Identification of barriers to clinical trials: The impact of education level. J Clin Oncol 29: 2011 (suppl; abstr 6003)
7. Meropol NJ, Buzaglo JS, Millard J, et al: Barriers to clinical trial participation as perceived by oncologists and patients. J Natl Compr Canc Netw 5: 655-664, 2007
8. Somkin CP, Altschuler A, Ackerson L, et al: Organizational barriers to physician participation in cancer clinical trials. Am J Manag Care 11:413-421, 2005
9. Gross CP, Filardo G, Mayne ST, et al: The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer 103:483-491, 2005
10. Kehl KL, Arora NK, Schrag D, et al: Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer. J Natl Cancer Inst 106:oii, 2014
11. Unger JM, Hershman DL, Albain KS, et al: Patient income level and cancer clinical trial participation. J Clin Oncol 31:536-542, 2013
12. HINTS: Awareness of clinical trials and attitudes about the use of personal medical information for research, HINTS Briefs, Number 20. Bethesda, MD: National Cancer Institute 2011
13. Klamerus JF, Bruinooge SS, Ye X, et al: The impact of insurance on access to cancer clinical trials at a comprehensive cancer center. Clin Cancer Res 16:5997-6003, 2010
14. Lara PN, Jr, Higdon R, Lim N, et al: Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. J Clin Oncol 19:1728-1733, 2001
15. Lara PN, Jr, Paterniti DA, Chiechi C, et al: Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 23:9282-9289, 2005
16. Wells AA, Zebrack B: Psychosocial barriers contributing to the under-representation of racial/ethnic minorities in cancer clinical trials. Soc Work Health Care 46:1-14, 2008
17. Albrecht TL, Eggly SS, Gleason ME, et al: Influence of clinical communication on patients' decisionmaking on participation in clinical trials. J Clin Oncol 26:2666-2673, 2008
18. BeLue R, Taylor-Richardson KD, Lin J, et al: African Americans and participation in clinical trials: Differences in beliefs and attitudes by gender. Contemp Clin Trials 27:498-505, 2006
19. Hussain-Gambles M: South Asian patients' views and experiences of clinical trial participation. Fam Pract 21:636-642, 2004
20. Nguyen TT, Somkin CP, Ma Y, et al: Participation of Asian-American women in cancer treatment research: a pilot study. J Natl Cancer Inst Monogr 2005:102-105, 2005
21. Tejeda HA, Green SB, Trimble EL, et al: Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 88:812-816, 1996
22. Tu S-P, Chen H, Chen A, et al: Clinical trials: Understanding and perceptions of female Chinese-American cancer patients. Cancer 104:2999-3005, 2005
23. Basche M, Baró n AE, Eckhardt SG, et al: Barriers to enrollment of elderly adults in early-phase cancer clinical trials. J Oncol Pract 4:162-168, 2008
24. Farmer DF, Jackson SA, Camacho F, et al: Attitudes of African American and low socioeconomic status white women toward medical research. J Health Care Poor Underserved 18:85-99, 2007
25. Denicoff AM, McCaskill-Stevens W, Grubbs SS, et al: The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and recommendations. J Oncol Pract 9:267-276, 2013
26. Meade CD, McKinney WP, Barnas GP: Educating patients with limited literacy skills: The effectiveness of printed and videotaped materials about colon cancer. Am J Public Health 84:119-121, 1994
27. Wilson EAH, Park DC, Curtis LM, et al: Media and memory: The efficacy of video and print materials for promoting patient education about asthma. Patient Educ Couns 80:393-398, 2010
28. Banda DR, Libin AV, Wang H, et al: A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials. Oncologist 17:708-714, 2012
29. Armstrong AW, Idriss NZ, Kim RH: Effects of video-based, online education on behavioral and knowledge outcomes in sunscreen use: A randomized controlled trial. Patient Educ Couns 83:273-277, 2011
30. Stanczyk NE, Crutzen R, Bolman C, et al: Influence of delivery strategy on messageprocessing mechanisms and future adherence to a Dutch computer-tailored smoking cessation intervention. J Med Internet Res 15:e28, 2013
31. Fleisher L, Ruggieri DG, Miller SM, et al: Application of best practice approaches for designing decision support tools: The preparatory education about clinical trials (PRE-ACT) study. Patient Educ Couns 96:63-71, 2014
32. Miller SM, Hudson SV, Egleston BL, et al: The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial. Psychooncology 22: 481-489, 2013
33. Manne S, Kashy D, Albrecht T, et al: Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: A mediational model. Med Decis Making 34:454-463, 2014
34. Miller SM, Diefenbach MA: The Cognitive-Social Health Information-Processing (C-SHIP) Model: A theoretical framework for research in behavioral oncology, in Krantz D (ed): Perspectives in Behavioral Medicine. Lawrence Erlbaum, Mahwah, NJ, 1998, pp 219-244
35. O'Connor AM: Validation of a decisional conflict scale. Med Decis Making 15:25-30, 1995
36. O'Connor AM: Consumer/patient decision support in the new millennium: Where should our research take us. Can J Nurs Res 29:7-19, 1997
37. O'Connor AM, Tugwell P, Wells GA, et al: Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Med Decis Making 18:295-303, 1998
38. Meropol NJ, Egleston BL, Buzaglo JS, et al: CONNECT Study Research Group: Cancer patient preferences for quality and length of life. Cancer 113: 3459-3466, 2008
39. Meropol NJ, Weinfurt KP, Burnett CB, et al: Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physicianpatient communication. J Clin Oncol 21:2589-2596, 2003
40. Weinfurt KP, Sulmasy DP, Schulman KA, et al: Patient expectations of benefit from phase I clinical trials: Linguistic considerations in diagnosing a therapeutic misconception. TheorMed Bioeth 24:329-344, 2003
41. Degner LF, Sloan JA, Venkatesh P: The Control Preferences Scale. Can J Nurs Res 29:21-43, 1997
42. Davis SW, Nealon EO, Stone JC: Evaluation of the National Cancer Institute's clinical trials booklet. J Natl Cancer InstMonogr 139-145, 1993
43. Hall MJ, Egleston B, Miller SM, et al: Barriers to participation in cancer prevention clinical trials. Acta Oncol 49:757-766, 2010
44. Bennett C, Graham ID, Kristjansson E, et al: Validation of a preparation for decision making scale. Patient Educ Couns 78:130-133, 2010
45. Stacey D, O'Connor AM, DeGrasse C, et al: Development and evaluation of a breast cancer prevention decision aid for higher-risk women. Health Expect 6:3-18, 2003
46. Holmes-Rovner M, Kroll J, Schmitt N, et al: Patient satisfaction with health care decisions: The satisfaction with decision scale. Med Decis Making 16:58-64, 1996
47. Dusetzina SB, Winn AN, Abel GA, et al: Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 32:306-311, 2014
48. Neugut AI, Subar M, Wilde ET, et al: Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 29:2534-2542, 2011
49. Shankaran V, Jolly S, Blough D, Ramsey SD: Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: A population-based exploratory analysis. J Clin Oncol 30:1608-1614, 2012
50. Wong YN, Egleston BL, Sachdeva K, et al: Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting. Med Care 51:838-845, 2013
51. Zafar SY, Peppercorn JM, Schrag D, et al: The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 18:381-390, 2013
52. US Government: The Patient Protection and Affordable Care Act (PPACA): US Government Printing Office Washington, DC, 2010, pp 124 stat. 893